Rhygaze
Developer of novel gene therapy designed to restore vision in patients. The company's therapy technology delivers a light-sensor gene specifically to cone cells that have lost light sensitivity, and r...
Valuation
$0
Share Price
N/A
Total Raised
$97.9M
Last Round
N/A